China Asset Management Co., Ltd.
Overview
China Asset Management Co., Ltd. is one of China's largest asset management firms, offering a wide range of investment products including mutual funds, ETFs, and services for institutional and retail clients.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| METiS Therapeutics | May 2026 | IPO | Co-investor |
| Duoning Biotechnology | Nov 2021 | Series C | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is China Asset Management Co., Ltd. based?
China Asset Management Co., Ltd. is headquartered in Beijing, China.
When was China Asset Management Co., Ltd. founded?
China Asset Management Co., Ltd. was founded in 1998.
How many portfolio companies does China Asset Management Co., Ltd. have?
China Asset Management Co., Ltd. has 3 portfolio companies in Caplight's dataset.
What are some companies in China Asset Management Co., Ltd.'s portfolio?
Portfolio companies visible on Caplight include METiS Therapeutics, Duoning Biotechnology.
What was China Asset Management Co., Ltd.'s most recent investment shown here?
China Asset Management Co., Ltd.'s most recent investment in this portfolio sample was in METiS Therapeutics in 2026.
What sectors does China Asset Management Co., Ltd. focus on?
China Asset Management Co., Ltd. focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Frontier & Industrial Tech.
What company stages does China Asset Management Co., Ltd. focus on?
Stage focus information for China Asset Management Co., Ltd. is not publicly available.
What is China Asset Management Co., Ltd.'s AUM?
China Asset Management Co., Ltd.'s assets under management are estimated between $418.6B and $423.5B.